NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014
Press Release
Read More
NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015
Press Release
Read More
NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014
Press Release
Read More
NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program
Press Release
Read More
Complete molecular risk stratification of de novo acute myeloid leukemia with intermediate cytogenetics using a nine-gene panel
Literature
Read More
Deep sequencing of peripheral blood plasma DNA as a reliable test for confirming the diagnosis of MDS
Literature
Read More
Determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma
Literature
Read More
Molecular profiling in confirming the diagnosis of early myelodysplastic syndrome
Literature
Read More